延长释放膜片对失脂症和三糖血症患者的安全性的长期影响:第三阶段,多中心,随机,开放标签,并行组研究
Hidenori Arai1, Shizuya Yamashita2, Eiichi Araki3,4
1National Center for Geriatrics and Gerontology.
Journal of atherosclerosis and thrombosis
|February 9, 2025
概括
佩马菲布拉特延长释放 (XR) 片在52周的时间内有效降低了失脂症患者的高甘油三 (TG). 给药时间 (早上与晚上) 没有影响TG降低,剂量调整改善了结果.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 脱脂症,特点是高甘油三 (TG),是心血管疾病的重要危险因素.
- 有效的长期治疗脱脂症对于患者的健康至关重要.
- 佩马纤维酸是一种用于管理脂质疾病的新型治疗剂.
研究的目的:
- 评估每天服用一次延长释放剂 (XR) 片的纤维酸的长期安全性和有效性,用于高TG的失脂症患者.
- 为了比较早晨与晚上服用纤维素XR对TG水平的影响.
- 评估pemafibrate XR剂量升级在初始反应不足的患者中的有效性.
主要方法:
- 一个多中心的,随机的,开放的标签,平行组,第三阶段的研究.
- 121名患有高TG的失脂症患者被分配给52周的早上或晚上XR治疗.
- 剂量根据禁食血清TG水平进行调整,主要终点是禁食血清TG的百分比变化.
主要成果:
- 禁食血清TG在早上和晚上给药组 (总体为-45.7%) 显着比基线下降.
- 在早上和晚上给药组之间没有观察到TG降低的统计学上显著差异.
- 剂量增加给了82名患者,57.3%的患者达到目标TG水平 (<150 mg/dL);不良事件通常是轻微的.
结论:
- 每天服用一次Pemafibrate XR是有效和安全的长期管理高TG在失脂症患者.
- 佩马纤维酸XR的时间 (早上或晚上) 不会影响其降低TG的疗效.
- 调整pemafibrate XR的剂量是一种可行的策略,可以在非响应患者中实现治疗目标.
相关概念视频
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
118
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
118
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
517
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
517
01:23Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
01:06Lipid Digestion
90.6K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
90.6K
01:29Cholesterol: Significance and Regulation
497
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
497